Hansoh Pharmaceutical Group strikes antibody-drug conjugate deal with Roche
China’s Hansoh Pharmaceutical Group said it struck a deal with Roche to develop a portfolio of antibody-drug conjugates. STAT reported the announcement in its Oct. 20, 2026 biotech roundup and said Hansoh described the transaction as having been made the day…
